Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

NURE vs HOMZ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NURE Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

NURE Overall Winner 6-Pillar Tally: NURE 0 – 0 HOMZ (6 Tie) Matrix Metrics: NURE 2 – 1 HOMZ

As of Nov 16, 2026, Nuveen Short-Term REIT ETF (NURE) is the stronger overall head-to-head candidate over Hoya Capital Housing ETF (HOMZ) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). NURE carries a Unified Composite Score of 39.5/100 (SELL) at $32.53 (N/M Forward P/E, N/A operating margin), whereas HOMZ carries 42.8/100 (HOLD) at $42.72 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While HOMZ currently prints a higher short-term Unified Composite Score (42.8/100 HOLD vs. NURE 39.5/100 SELL), NURE captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
  • Technical & Structure Timing Caution: NURE trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.8); meanwhile HOMZ is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NURE vs HOMZ
NURE Cboe BZX Head-to-Head Winner
Nuveen Short-Term REIT ETF
Institutional Equity
$32.53
+0.42% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.26β · 18% Vol
Unified Composite Score
39.5 / 100 SELL
Tech 29.0 Fund 33.0 Flow 50.0 Mom 11.1
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 62
RSI-14: 61.8 · SMA20: $32.01 · SMA50: $30.80
HOMZ NYSE Arca
Hoya Capital Housing ETF
Institutional Equity
$42.72
-0.54% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.65β · 33% Vol
Unified Composite Score
42.8 / 100 HOLD
Tech 46.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.7%) with fading momentum, RSI 50
RSI-14: 49.8 · SMA20: $42.88 · SMA50: $42.06

6-Pillar Scorecard Institutional Category Breakdown (NURE 0 – 0 HOMZ)

Columns: Metric · NURE · HOMZ
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 23.4% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Distribution
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NURE (2) vs HOMZ (1)
Institutional Metric NURE HOMZ Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
86% ($27–$33) 29% ($40–$50) Stronger Trend NURE
Beta / 30D Volatility
Risk Regime
0.26β · 18% Vol 0.65β · 33% Vol Lower Realized Risk NURE
Unified Institutional Score
Composite Signal
39.5 / 100 (SELL) 42.8 / 100 (HOLD) Higher Composite HOMZ
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NURE +1.83 pp
NURE: +6.38% · HOMZ: +4.55%
3M Horizon NURE +9.25 pp
NURE: +2.56% · HOMZ: -6.69%
6M Horizon NURE +7.91 pp
NURE: +8.66% · HOMZ: +0.75%
1Y Horizon NURE +21.24 pp
NURE: +16.73% · HOMZ: -4.51%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NURE vs HOMZ. Trailing 12-month operating profitability (NURE N/A vs HOMZ N/A) and valuation multiples (NURE N/M vs HOMZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

NURE ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
HOMZ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NURE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NURE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HOMZ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 23.4%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HOMZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NURE Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
HOMZ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ NURE vs HOMZ Key Questions & Quantitative Answers

As of Nov 16, 2026, Nuveen Short-Term REIT ETF (NURE) is the stronger overall head-to-head candidate over Hoya Capital Housing ETF (HOMZ) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). NURE carries a Unified Composite Score of 39.5/100 (SELL) at $32.53 (N/M Forward P/E, N/A operating margin), whereas HOMZ carries 42.8/100 (HOLD) at $42.72 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While HOMZ currently prints a higher short-term Unified Composite Score (42.8/100 HOLD vs. NURE 39.5/100 SELL), NURE captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: NURE trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.8); meanwhile HOMZ is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NURE and HOMZ split Growth & Scale metrics: NURE posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with HOMZ at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, NURE generates N/A in USD-normalized revenue versus N/A for HOMZ. In operating R&D and SG&A reinvestment, NURE deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for HOMZ.

NURE and HOMZ trade at balanced relative valuation multiples. NURE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas HOMZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NURE (N/A ROE) versus HOMZ (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, NURE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.26β · 18% Vol realized risk). By comparison, HOMZ carries 23.4% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.65β · 33% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.